Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, 101 Merrimac St, 10th Floor, Boston, MA 02114-4724, USA.
Radiology. 2011 Dec;261(3):692-8. doi: 10.1148/radiol.11110155.
In June 2009, the Federal Coordinating Council for Comparative Effectiveness Research submitted a report to the President and Congress in which the Council described the purpose of comparative effectiveness research (CER) as developing evidence-based information for interventions and determining under what circumstances an intervention is effective (1). With the enactment of the Patient Protection and Affordable Care Act, a Patient-centered Outcomes Research Institute (PCORI) was established to assist decision makers in making evidence-based health decisions through synthesis and dissemination of clinical CER of health interventions (2). Its founding has underscored a heightened need for health policy makers to consider the impact of health care technologies on final outcomes of interest--for example, functional status, quality of life, disability, major clinical events, and mortality (3-5).
2009 年 6 月，联邦协调理事会（Federal Coordinating Council）提交了一份报告给总统和国会，该报告描述了比较效果研究（comparative effectiveness research，CER）的目的是为干预措施提供基于证据的信息，并确定干预措施在什么情况下是有效的。随着《患者保护与平价医疗法案》（Patient Protection and Affordable Care Act）的颁布，成立了一个以患者为中心的成果研究所（Patient-centered Outcomes Research Institute，PCORI），旨在通过综合和传播健康干预措施的临床 CER，协助决策者做出基于证据的健康决策。该研究所的成立凸显了卫生政策制定者更加需要考虑医疗技术对最终关注结果的影响，例如功能状态、生活质量、残疾、主要临床事件和死亡率。
